{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/stroke-tia/management/management-of-long-term-complications-of-stroke/","result":{"pageContext":{"chapter":{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke","depth":2,"htmlHeader":"<!-- begin field c33a4167-3b4f-49ec-810a-4ca51d7d0e90 --><h2>Scenario: Management of long term complications of stroke</h2><!-- end field c33a4167-3b4f-49ec-810a-4ca51d7d0e90 -->","summary":"The management of the complications of stroke will usually be started in secondary care and continued by specialists. However, new problems can present in primary care and are summarized in this section. Often referral to an appropriate specialist is necessary.","htmlStringContent":"<!-- begin item b9f13a60-1bbe-4994-8f59-d20917775a52 --><!-- begin field e00c1428-fa83-4903-9d20-acbc015b9d34 --><p>From age 16 years onwards.</p><!-- end field e00c1428-fa83-4903-9d20-acbc015b9d34 --><!-- end item b9f13a60-1bbe-4994-8f59-d20917775a52 -->","topic":{"id":"f543bb01-4edc-57a6-ba31-aaa6b6b6e6e8","topicId":"63954e32-591d-4f33-bcbb-3fdecfc69796","topicName":"Stroke and TIA","slug":"stroke-tia","lastRevised":"Last revised in August 2020","chapters":[{"id":"3690cd7d-0a6b-548a-a527-b276c3924bab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aef0c419-4ee2-52b6-b781-c8afa9a11104","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3fa3210c-0be8-5167-adb3-6c05aaef00bc","slug":"changes","fullItemName":"Changes"},{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update"}]},{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"08277b76-a6c4-566a-a594-131c32067735","slug":"goals","fullItemName":"Goals"},{"id":"acf4fa85-325c-5018-8bc2-9d877522bf6f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"18bc44dc-3e6b-58ae-9d3c-abca76b13c16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"08107877-662b-59e6-a30a-b21e19250f23","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff061807-ab05-5af8-8dd4-01db71526d0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a0b319c1-8df3-5206-93ce-302f6b981e82","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a0bcd779-defb-50a7-86f6-ab4b2c701ac7","slug":"definition","fullItemName":"Definition"},{"id":"c40d717d-0b67-5cb2-b86c-c67045400115","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"d1569ff2-5da1-51a0-9720-75ad88c0ad86","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ee8fc150-6899-5c75-a0d0-6241055dfd09","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d5730239-5d67-598b-b9d1-f339079de3eb","slug":"complications","fullItemName":"Complications"},{"id":"9b730ca3-d3ee-552b-8145-f6eadf244a63","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"caea5ae7-0be8-5c7c-8bef-7162c7171e9d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"67902a93-a36b-58c6-a67a-3eb89654460c","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2bc808d1-f905-575d-90b2-8481eb492905","slug":"assessment","fullItemName":"Assessment"},{"id":"6562a8bf-1396-58ba-b1b9-a1914e4adebe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","fullItemName":"Management","slug":"management","subChapters":[{"id":"1baf2362-0da4-599f-8f9a-12d0124253a0","slug":"suspected-acute-stroke","fullItemName":"Scenario: Suspected acute stroke"},{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack"},{"id":"91d820f4-4249-556c-99e2-4ac86d3ebd2a","slug":"secondary-prevention-following-stroke-tia","fullItemName":"Scenario: Secondary prevention following stroke and TIA"},{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke"}]},{"id":"30a83b67-7804-5b41-a647-98d32dce018a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ebfe1dbe-0d9c-5a26-82b4-4d0a308a19ac","slug":"antiplatelet-treatment","fullItemName":"Antiplatelet treatment"}]},{"id":"279444c7-61df-5f92-b512-c703ae6cb9fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"72590587-c86f-5da1-b397-b7e6cc757702","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7ba85ca6-985e-5af5-b223-0c27f7066797","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18f7eefe-52bd-5ad8-a39c-b96d270599ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8fed8545-5194-53a4-b547-2d6a402857f5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"216e65b7-f638-5b35-ad86-30270fbea649","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e1ee5a80-c40c-5354-859f-829dfb3e3f3f","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Management of long term complications of stroke","depth":3,"htmlHeader":"<!-- begin field 9c16171c-4629-400a-8aeb-bd39ab878cc9 --><h3>How do I manage complications of stroke in primary care?</h3><!-- end field 9c16171c-4629-400a-8aeb-bd39ab878cc9 -->","summary":null,"htmlStringContent":"<!-- begin item 635767e2-0d95-4889-a6b2-ba2dfc4de069 --><!-- begin field 30447628-e581-4c6d-81ae-0046ae93f7ae --><ul><li>People with stroke should be discharged from secondary care with a comprehensive health and social care plan. People with disabilities related to stroke should be followed up within 72 hours by a specialist stroke rehabilitation team.<ul><li>Reassure the person and their family/cares that they can self-refer, usually with the support of a GP or named contact, if further stroke rehabilitation services are needed in the future.</li><li>Discuss any complex rehabilitation issues or problems with management of complications of stroke with a stroke specialist.</li></ul></li><li><strong>When people with a history of stroke consult (for whatever reason), be alert for problems that may require new assessment and management:</strong><ul><li><strong>Bowel and bladder problems</strong> — continence will be assessed and management initiated by the specialist stroke team in secondary care. On transfer of care, people with ongoing incontinence should be followed up by community continence services.<ul><li>Treatment of continence issues depends on the underlying cause and may include timed toileting, prompted voiding, bladder retraining, pelvic floor exercises, and in some cases drug treatments.</li><li>Do not insert indwelling (urethral) catheter unless indicated for relief of urinary retention or if fluid balance is critical.</li><li>If urinary tract infection is a problem, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a> and <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-women/\">Urinary tract infection (lower) - women</a> for further information on treatment.</li><li>If constipation is a problem give advice on diet, fluid intake and exercise, review medication to identify constipating drugs, consider toileting routines and prescription of laxatives. For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/constipation/\">Constipation</a>.</li></ul></li><li><strong>Fatigue</strong> — tiredness and lack of energy following stroke are typically not relieved by rest and can cause considerable morbidity.<ul><li>Assess the person for mental and physical factors that may contribute to fatigue (such as depression, anxiety, thyroid disorders, infection, adverse effects of medication and disturbance of sleep by pain or sleep apnoea). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a>, <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a>, <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-women/\">Urinary tract infection (lower) - women</a> for further information.</li><li>Treat any reversible causes or exacerbating factors.</li><li>Provide the person and their family/carers with information and help in anticipating and managing fatigue such as daily routines, modified tasks which balance activity and rest, planned exercise schedules, and sleep hygiene.</li></ul></li><li><strong>Nutrition and hydration</strong> — regularly monitor dietary intake and nutritional status of people with nutritional problems.<ul><li>Refer to a dietician if oral intake of nutrition and fluids is inadequate or food or fluid consistency needs modified. </li><li>Discuss with or refer to a stroke specialist if the person is unable to swallow adequate food and fluids or is unable to tolerate nasogastric tube feeding initiated in hospital.</li><li>Ensure that people who have difficulty self-feeding after stroke have access to appropriate equipment and assistance to facilitate independent and safe feeding.</li></ul></li><li><strong>Cognitive dysfunction</strong><ul><li>Consider screening all people with stroke and TIA for cognitive impairment with an appropriate tool such as the Mini-Mental State Examination.</li><li>If appropriate, refer people with suspected cognitive dysfunction for neuropsychological assessment. </li><li>Ensure that decisions made with or on behalf of people with stroke are in line with the principles of the Mental Capacity Act 2005 (or in Scotland the Adults with Incapacity (Scotland) Act 2000).</li><li>For more information on assessment, referral and the Mental Capacity Act, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/\">Dementia</a>.</li></ul></li><li><strong>Mood and wellbeing</strong> — consider depression in all people with stroke. If one mood disorder (such as depression) is identified, assess for others (such as anxiety). <ul><li>If the person has a severe or persistent mood disorder after stroke discuss with a stroke physician/refer to psychiatry or psychology.</li><li>If the person has aphasia and low mood after stroke consider referring for individual behavioural therapy.</li><li>Consider brief psychological interventions (such as motivational interviewing or problem-solving therapy) before antidepressant medication. If treating with antidepressant medication, monitor for adverse effects and treat for at least four months beyond initial recovery — if mood has not improved after 2-4 weeks, check adherence before considering a dose increase or alternative antidepressant.</li><li>Psychosocial interventions such as increased social interaction, increased exercise, or psychosocial education groups may be helpful.</li><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> and <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>.</li></ul></li><li><strong>Mouth care</strong><ul><li>Advise people with stroke (in particular those who are tube fed or with swallowing problems) and their families/carers to carry out mouth care at least 3 times a day. Mouth care should include brushing teeth and cleaning gums with toothpaste and/or chlorhexidine dental gel, removing excess secretions and applying lip balm.</li><li>Advise people with stroke who have dentures to put them in during the day, clean them regularly with a toothbrush, toothpaste and/or chlorhexidine dental gel and have regular check-ups and replacement dentures ill-fitting, damaged or lost.</li><li>People living in a care home after stroke should receive mouth care from appropriately trained staff.</li></ul></li><li><strong>Pain - neuropathic</strong><ul><li>Treat people with central post-stroke pain with amitriptyline, gabapentin or pregabalin. For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/neuropathic-pain-drug-treatment/\">Neuropathic pain - drug treatment</a>.</li><li>Arrange regular review including monitoring for adverse effects and the continued need for medication — consider gradual reductions in dose over time if improvement is sustained.</li><li>If unsure about treatment seek advice from a stroke specialist.</li></ul></li><li><strong>Pain - musculoskeletal</strong><ul><li>Pain can be caused by prolonged immobility and abnormal posture or by exacerbation of pre-existing conditions such as osteoarthritis. </li><li>Assess the person’s movement, posture and moving and handling techniques to ensure they are optimised to reduce pain.</li><li>Offer people with ongoing musculoskeletal pain pharmacological treatment with simple analgesic drugs such as paracetamol, topical non-steroidal anti-inflammatory drugs (NSAIDs) or transcutaneous electrical nerve stimulation (TENS) before considering opioid analgesics.</li><li>If the person has shoulder pain due to functional loss in the arm give advice on proper positioning of the arm with the weight of the limb supported, correct handling of the arm to prevent mechanical stress and excessive range of movement, maintenance of range of shoulder movement and motor retraining, and avoidance of overhead arm slings and pulleys. Offer regular simple analgesia and only offer intra-articular steroid injections if the person also has inflammatory arthritis.</li><li>For further information see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li></ul></li><li><strong>Sexual dysfunction</strong><ul><li>Ask people with stroke, soon after discharge and at their 6-month and annual reviews about sexual dysfunction and give partners the opportunity to discuss any concerns.</li><li>If the person reports sexual dysfunction and wants help, assess for reversible causes (including medication), reassure them that sexual activity is not contraindicated and very unlikely to precipitate a further stroke.</li><li>Assess men for erectile dysfunction and the use of a phosphodiesterase type 5 inhibitor (such as sildenafil) — phosphodiesterase type 5 inhibitors should not be used for 3 months after stroke (blood pressure must be controlled).</li><li>Refer to a professional with expertise in psychosexual problems if sexual dysfunction persists.</li><li>For further information see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/erectile-dysfunction/\">Erectile dysfunction</a>.</li></ul></li><li><strong>Spasticity and contractures</strong> — spasticity and development of contractures are common following stroke and can lead to discomfort and pain.<ul><li>Splinting may be advised by specialists to help manage tone, reduce pain and improve range of movement and function.</li></ul></li><li><strong>End of life care</strong><ul><li>Ensure people with stroke who are nearing the end of life are cared for by staff trained in end of life care and have access to the specialist palliative care team when needed.</li><li>Do not restrict oral food and/or fluid intake in people with stroke who are receiving end of life care if such restrictions will exacerbate suffering.</li><li>For further information on end of life care see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul></li></ul></li></ul><!-- end field 30447628-e581-4c6d-81ae-0046ae93f7ae --><!-- end item 635767e2-0d95-4889-a6b2-ba2dfc4de069 -->","subChapters":[{"id":"b6bf9d9b-34ca-5b33-9b2b-90f706b7b0e7","slug":"basis-for-recommendation-835","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field b626fbae-066a-48d3-9f22-956e0397020d --><h4>Basis for recommendation</h4><!-- end field b626fbae-066a-48d3-9f22-956e0397020d -->","summary":null,"htmlStringContent":"<!-- begin item 8357ac2e-76eb-41c0-b627-b94ad3acfe18 --><!-- begin field 8de56acd-7303-4419-aaa6-2624f434b20c --><p>The recommendations on management of complications of stroke in primary care are based on the clinical guidelines <em>Stroke rehabilitation in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">National Clinical Guideline Centre, 2013</a>], <em>Stroke and transient ischemic attack: acute and long term management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">British Columbia Medical Association, 2015</a>], <em>National clinical guideline for stroke</em>.<em> Prepared by the Intercollegiate Stroke Working Party</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>], and <em>Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Winstein, 2016</a>] and the Canadian Stroke Best Practice Recommendations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Eskes, 2015</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hankey, 2014</a>].</p><h5>Continence</h5><ul><li>Recommendations are based on the clinical guideline <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] which due to a lack of high quality evidence in this area relies largely on consensus opinion.</li></ul><h5>Fatigue</h5><ul><li>Recommendations are based on the clinical guideline <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] which refers to a Cochrane review of interventions for post-stroke fatigue [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Wu, 2015</a>], a systematic review of fatigue scales in people with stroke [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Mead, 2007</a>] and consensus opinion as the evidence base.</li></ul><h5>Mood and wellbeing</h5><ul><li>The recommendations on anxiety, depression and psychological distress are based on the clinical guidelines <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] and the Canadian Stroke Best Practice Recommendations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Eskes, 2015</a>].<ul><li>Two Cochrane reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Campbell Burton, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Mead, 2012</a>] have concluded that psychological measures and drug treatment appear useful for anxiety.</li><li>There is insufficient evidence on drug therapy for prevention of depression. Brief psychological interventions (such as motivational interviewing) may help prevent and treat depression [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hackett, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Watkins, 2011</a>].</li><li>Drug therapy alone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hackett, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Mead, 2012</a>] or in combination with psychological therapies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Mitchell, 2009</a>] may help treat depression.</li><li>Individual behaviour therapy has been found to be more effective than usual care in improving mood in people with aphasia due to stroke [Thomas 2013].</li></ul></li></ul><h5>Pain</h5><ul><li>There is little high quality evidence on management of central post stroke pain.</li><li>Many anticonvulsant and antidepressant drugs have little evidence in their favour despite frequent use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].</li><li>The evidence to the recommendations in the <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] are based on the NICE guideline CG173 on neuropathic pain [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">NICE, 2013</a>]. NICE recommend initial use of amitryptaline, duloxetine, gabapentin or pregabalin for neuropathic pain, switching between them where response is inadequate.</li></ul><ul><li>The recommendations on treatment of musculoskeletal pain in the <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] are based on NICE guideline <em>Osteoarthritis: care and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">NICE, 2014b</a>] and consensus opinion.</li></ul><h5>Sexual dysfunction</h5><ul><li>The <em>National clinical guideline for stroke</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] states that although there is no reason to suspect people are at increased risk of side effects of phosphodiesterase type 5 inhibitors following stroke it is the consensus opinion of the working party to wait for 3 months after stroke before prescribing them, once blood pressure is adequately controlled.</li></ul><h5>End of life care</h5><ul><li>There are few good quality studies into end-of-life care in stroke and most evidence comes from cancer care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].<ul><li>Rigid adherence to recommendations on restricting access to oral food/fluid in cases where there is risk of aspiration could, in palliative care, exacerbate suffering [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].</li></ul></li></ul><!-- end field 8de56acd-7303-4419-aaa6-2624f434b20c --><!-- end item 8357ac2e-76eb-41c0-b627-b94ad3acfe18 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}